牛牛AI助理已提取核心訊息
AbbVie Inc. (AbbVie) has announced the upcoming 2024 Annual Meeting of Stockholders scheduled for May 3, 2024. The meeting will be held virtually, allowing stockholders to attend, vote, and submit questions online. The agenda includes the election of five directors to serve until the 2027 Annual Meeting, the ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2024, advisory votes on executive compensation and the frequency of future stockholder advisory votes on executive compensation, and a management proposal to eliminate supermajority voting requirements. Additionally, three stockholder proposals will be considered if properly presented. The board recommends voting for the ratification of Ernst & Young LLP, for the approval of named executive officers' compensation, for annual advisory approvals of executive compensation, for the management proposal to eliminate supermajority voting, and against each of the stockholder proposals. The meeting will also address any other matters that may properly come before the meeting.
AbbVie Inc. (AbbVie) has announced the upcoming 2024 Annual Meeting of Stockholders scheduled for May 3, 2024. The meeting will be held virtually, allowing stockholders to attend, vote, and submit questions online. The agenda includes the election of five directors to serve until the 2027 Annual Meeting, the ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2024, advisory votes on executive compensation and the frequency of future stockholder advisory votes on executive compensation, and a management proposal to eliminate supermajority voting requirements. Additionally, three stockholder proposals will be considered if properly presented. The board recommends voting for the ratification of Ernst & Young LLP, for the approval of named executive officers' compensation, for annual advisory approvals of executive compensation, for the management proposal to eliminate supermajority voting, and against each of the stockholder proposals. The meeting will also address any other matters that may properly come before the meeting.
艾伯維公司（AbbVie）宣佈了即將於2024年5月3日舉行的2024年年度股東大會。會議將以虛擬方式舉行，允許股東在線出席、投票和提交問題。該議程包括選舉五名董事，任期至2027年年會，批准安永會計師事務所爲艾伯維2024年獨立註冊會計師事務所，關於高管薪酬的諮詢投票和未來股東就高管薪酬進行諮詢投票的頻率，以及取消絕大多數投票要求的管理層提案。此外，如果提交得當，將考慮三份股東提案。董事會建議投票批准安永會計師事務所，批准指定執行官的薪酬，對高管薪酬的年度諮詢批准，管理層取消絕大多數投票的提議，並反對每項股東提案。會議還將討論可能在會議之前適當提出的任何其他事項。
艾伯維公司（AbbVie）宣佈了即將於2024年5月3日舉行的2024年年度股東大會。會議將以虛擬方式舉行，允許股東在線出席、投票和提交問題。該議程包括選舉五名董事，任期至2027年年會，批准安永會計師事務所爲艾伯維2024年獨立註冊會計師事務所，關於高管薪酬的諮詢投票和未來股東就高管薪酬進行諮詢投票的頻率，以及取消絕大多數投票要求的管理層提案。此外，如果提交得當，將考慮三份股東提案。董事會建議投票批准安永會計師事務所，批准指定執行官的薪酬，對高管薪酬的年度諮詢批准，管理層取消絕大多數投票的提議，並反對每項股東提案。會議還將討論可能在會議之前適當提出的任何其他事項。
有用
沒用